Skinjo: Phages, Precision and the Need for Evidence

By evening, Skinjo has reduced the invisible war to three colours: concrete grey, black, oxidized red. A bacterial cell fills the painted field. Along its edge, phages gather like small, angular landing craft. The stillness of the picture conceals the violence of the process.

Bacteriophages are viruses that infect bacteria, not human cells. Those used to kill bacteria can hijack their hosts to make more phages, ultimately breaking the cells open. Some can destroy bacteria that resist antibiotics. Yet specificity is both the promise and the difficulty: a phage does not attack every bacterium. The right match matters.

Skinjo leaves a strip of bare ground beside the painted cell. It is tempting to fill it with a victory colour. Instead, the empty space holds what the picture cannot establish: whether a treatment will work safely and reliably in patients.

WHO Europe’s February 2025 fact sheet describes phage therapy as used mainly on compassionate grounds when other treatments have failed, with more clinical evidence needed before wider use. That is neither a dismissal nor a declaration of success. It is a reason to investigate carefully.

The side light catches each raised edge of paint. Skinjo studies the clustered forms without adding a triumphant final stroke. Against resistant infections, this precision offers hope. Hope still needs evidence.

Source: WHO Europe, “Bacteriophages and their use in combating antimicrobial resistance.”